These constraints from the BTNX NTS are hugely pertinent, as we observed e.g. etodesnitazene to own the same in vitro potency and efficacy as fentanyl [7, thirteen] and as it might perhaps give PWUD a Wrong feeling of safety. Additionally, the detectability of nitazene analogues in drug samples can be impacted by solubility challenges, as highlight